Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirca Lazzaretti

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Research|August 19, 2007
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironmentNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Plos One|November 1, 2008
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCRFederica Rizzi, Lucia Belloni, Pellegrino Crafa, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Frontiers in Bioscience (Landmark Edition)|January 7, 2014
CD38 and bone marrow microenvironmentAntonella Chillemi, Gianluca Zaccarello, Valeria Quarona, et al.
Haematologica|November 4, 2006
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survivalNicola Giuliani, Sabrina Bonomini, Paola Romagnani, et al.
Cancer Research|August 16, 2008
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesionsNicola Giuliani, Gina Lisignoli, Simona Colla, et al.
Blood|March 21, 2007
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patientsNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Journal of Parasitology Research|October 29, 2010
Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazoleAnnamaria Buschini, Lisa Ferrarini, Susanna Franzoni, et al.
Blood|October 7, 2003
Do human myeloma cells directly produce basic FGF?Simona Colla, Francesca Morandi, Mirca Lazzaretti, et al.
Blood|October 24, 2002
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone diseaseNicola Giuliani, Simona Colla, Roberto Sala, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Research|August 19, 2007
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironmentNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Plos One|November 1, 2008
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCRFederica Rizzi, Lucia Belloni, Pellegrino Crafa, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Frontiers in Bioscience (Landmark Edition)|January 7, 2014
CD38 and bone marrow microenvironmentAntonella Chillemi, Gianluca Zaccarello, Valeria Quarona, et al.
Haematologica|November 4, 2006
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survivalNicola Giuliani, Sabrina Bonomini, Paola Romagnani, et al.
Cancer Research|August 16, 2008
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesionsNicola Giuliani, Gina Lisignoli, Simona Colla, et al.
Blood|March 21, 2007
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patientsNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Journal of Parasitology Research|October 29, 2010
Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazoleAnnamaria Buschini, Lisa Ferrarini, Susanna Franzoni, et al.
Blood|October 7, 2003
Do human myeloma cells directly produce basic FGF?Simona Colla, Francesca Morandi, Mirca Lazzaretti, et al.
Blood|October 24, 2002
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone diseaseNicola Giuliani, Simona Colla, Roberto Sala, et al.
Pageof 3